Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 301 | $368.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 302 | $363.79M | Healthcare | Biotechnology | United States | Nasdaq |
| 303 | $361.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 304 | $360.55M | Healthcare | Medical Devices | United States | Nasdaq |
| 305 | $352.70M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 306 | $351.93M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 307 | $349.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 308 | $347.36M | Healthcare | Medical Devices | United States | Nasdaq |
| 309 | $345.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 310 | $344.46M | Healthcare | Medical Devices | United States | Nasdaq |
| 311 | $337.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 312 | $332.70M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 313 | $330.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 314 | $330.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 315 | $328.22M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 316 | $327.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 317 | $323.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 318 | $318.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 319 | $316.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 320 | $312.13M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 321 | $304.86M | Healthcare | Medical Devices | United States | Nasdaq |
| 322 | $302.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 323 | $302.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 324 | $298.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 325 | $296.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 326 | $294.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 327 | $292.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 328 | $292.39M | Healthcare | Medical Devices | United States | Nasdaq |
| 329 | $290.26M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 330 | $288.32M | Healthcare | Biotechnology | United States | Nasdaq |
| 331 | $287.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 332 | $287.01M | Healthcare | Biotechnology | United States | Nasdaq |
| 333 | $286.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 334 | $285.57M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 335 | $285.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 336 | $283.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 337 | $281.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 338 | $281.00M | Healthcare | Medical Devices | United States | Nasdaq |
| 339 | $280.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 340 | $279.67M | Healthcare | Medical Devices | United States | Nasdaq |
| 341 | $279.38M | Healthcare | Pharmaceuticals | United States | NYSE |
| 342 | $274.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 343 | $272.51M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 344 | $268.92M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 345 | $267.16M | Healthcare | Medical Devices | United States | Nasdaq |
| 346 | $264.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 347 | $260.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 348 | $260.02M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 349 | $256.81M | Healthcare | Biotechnology | United States | Nasdaq |
| 350 | $256.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 351 | $254.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 352 | $254.07M | Healthcare | Pharmaceuticals | United States | NYSE |
| 353 | $253.56M | Healthcare | Biotechnology | United States | Nasdaq |
| 354 | $253.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 355 | $253.06M | Healthcare | Biotechnology | United States | Nasdaq |
| 356 | $252.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 357 | $252.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 358 | $250.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 359 | $249.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 360 | $248.76M | Healthcare | Medical Devices | United States | Nasdaq |
| 361 | $248.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 362 | $246.69M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 363 | $246.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 364 | $246.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 365 | $244.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 366 | $242.38M | Healthcare | Medical Devices | United States | Nasdaq |
| 367 | $238.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 368 | $237.36M | Healthcare | Biotechnology | United States | Nasdaq |
| 369 | $236.60M | Healthcare | Biotechnology | United States | Nasdaq |
| 370 | $232.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 371 | $231.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 372 | $229.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 373 | $228.19M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 374 | $220.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 375 | $219.82M | Healthcare | Biotechnology | United States | Nasdaq |
| 376 | $218.88M | Healthcare | Biotechnology | United States | Nasdaq |
| 377 | $215.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 378 | $215.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 379 | $213.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 380 | $208.15M | Healthcare | Biotechnology | United States | Nasdaq |
| 381 | $206.53M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 382 | $205.19M | Healthcare | Medical Devices | United States | Nasdaq |
| 383 | $204.22M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 384 | $203.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 385 | $202.85M | Healthcare | Biotechnology | United States | Nasdaq |
| 386 | $202.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 387 | $197.75M | Healthcare | Biotechnology | United States | Nasdaq |
| 388 | $197.71M | Healthcare | Biotechnology | United States | Nasdaq |
| 389 | $197.54M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 390 | $195.46M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 391 | $195.28M | Healthcare | Medical Devices | United States | Nasdaq |
| 392 | $194.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 393 | $193.28M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 394 | $192.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 395 | $192.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 396 | $191.18M | Healthcare | Biotechnology | United States | Nasdaq |
| 397 | $190.44M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 398 | $189.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 399 | $189.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 400 | $189.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 750 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.